See every side of every news story
Published loading...Updated

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 18.0% in February

Summary by modernreaders.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 289,400 shares, a decline of 18.0% from the February 13th total of 353,000 shares. Approximately 1.3% of the shares of the stock are short sold. Based on an average daily trading volume, of 263,000 shares, the days-to-cover ratio is presently …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernreaders.com broke the news in on Tuesday, March 18, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.